𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Validation and evaluation of fecal calprotectin assays in pediatric inflammatory bowel disease

✍ Scribed by Kittanakom, Saranya; Sharif Shajib, Md.; Hinzmann, Celynne; Garvie, Kristine; Turner, Joceline; Brooks, Dan; Odeh, Sufian; Issenman, Robert; Chetty, V. Tony; Macri, Joseph; Khan, Waliul


Book ID
125860609
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
179 KB
Volume
47
Category
Article
ISSN
0009-9120

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Fecal calprotectin is useful in predicti
✍ Dorota Walkiewicz; Steven L. Werlin; Daryl Fish; Mathew Scanlon; Patrick Hanaway πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 119 KB

Background: Fecal calprotectin (FC) has been proposed as a noninvasive surrogate marker to determine the degree of intestinal inflammation and predicting relapse in patients with inflammatory bowel disease (IBD). The aim was to compare FC levels in IBD and healthy controls, to correlate FC levels wi

Fecal S100A12 and fecal calprotectin as
✍ Marc A. Sidler; Steven T. Leach; Andrew S. Day πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 123 KB

## Background: Fecal calprotectin is a sensitive marker for gut inflammation. recently, we have established that a related protein, s100a12, is elevated in the feces of children with inflammatory bowel disease (ibd). this may represent a specific and sensitive disease marker. the objective was to i

Fecal calprotectin and lactoferrin for t
✍ Javier P. Gisbert; Fernando Bermejo; Jose-LΓ‘zaro PΓ©rez-Calle; Carlos Taxonera; I πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 181 KB

## Background: The purpose of the study was to determine the role of fecal calprotectin and lactoferrin in the prediction of inflammatory bowel disease relapses, both in patients with ulcerative colitis (uc) and crohn's disease (cd), in a large, long-term, follow-up study. ## Methods: The prospec